STOCKHOLDERS' EQUITY (Details)					3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 14, 2021 USD ($) $ / shares shares	Sep. 10, 2021 USD ($) $ / shares shares	Dec. 14, 2020 USD ($) $ / shares shares	May 29, 2020 USD ($) $ / shares	Sep. 30, 2021 USD ($) $ / shares shares	Sep. 30, 2020 USD ($)	Sep. 30, 2021 USD ($) $ / shares shares	Sep. 30, 2020 USD ($)	Dec. 31, 2020 USD ($) $ / shares shares	Oct. 04, 2020 USD ($)	Jun. 01, 2020 USD ($)	Mar. 31, 2020 $ / shares shares
STOCKHOLDERS' EQUITY
Value of shares issued during the period					$ 1,073,446	$ 3,000,000	$ 1,073,446	$ 3,100,000
Exercise price of warrants | $ / shares												$ 1.00
Common stock, par value (in dollars per share) | $ / shares		$ 0.001			$ 0.001		$ 0.001		$ 0.001
Preferred stock, par value (in dollars per share) | $ / shares					$ 0		$ 0		$ 0
Preferred stock, shares authorized | shares					5,000,000		5,000,000		5,000,000
Number of warrants per unit | shares												1
Deemed dividend								$ 98,000
Series A Preferred
STOCKHOLDERS' EQUITY
Value of shares issued during the period		$ 1,180,000
Number of common shares issued | shares		1,180
Purchase price per unit | $ / shares		$ 1,000
Number of units issued | shares		1,180
Aggregate amount sold		$ 1,180,000
Number of common stock issuable for each preferred share | shares	1,000	1,000
Number of preferred shares per unit | shares		1
Minimum capital raise	$ 5,000,000	$ 5,000,000
Preferred stock, par value (in dollars per share) | $ / shares	$ 0
Preferred stock, shares authorized | shares	5,000
Preferred stock, voting rights	None
Preferred stock, dividend (percentage)	6.00%
2020 Capital Raise
STOCKHOLDERS' EQUITY
Conversion ratio				75
Exercise price of warrants | $ / shares			$ 0.4917	$ 0.5565
Term of warrants				5 years
Debt issuance costs, net				$ 2,173,074
Warrants exercisable (in shares) | shares									0
Beneficial ownership limitation (as a percent)									9.99%
Notice period									61 days
Deemed dividend			$ 732,494
Proceeds from sale of securities									$ 3,000,000
Shares of common stock sold | shares									7,532,010
Sale of stock, purchase price per share | $ / shares				$ 0.3983					$ 0.5565
Warrants to purchase | shares			1,631,000						5,649,007
Outstanding balances of existing holders for which the Company will seek an extended maturity date										$ 2,331,000	$ 2,331,000
Amount of notes with extended maturity date										$ 600,000
Exercise price, as a percentage of common stock price				100.00%
2020 Capital Raise | Minimum
STOCKHOLDERS' EQUITY
Proceeds from sale of securities				$ 2,185,000
Exercise price of additional warrants | $ / shares				$ 0.45
2020 Capital Raise | Maximum
STOCKHOLDERS' EQUITY
Proceeds from sale of securities				$ 3,000,000
Exercise price of additional warrants | $ / shares				$ 0.56
Preferred Warrants
STOCKHOLDERS' EQUITY
Exercise price of warrants | $ / shares	$ 1.05
Term of warrants	5 years
Number of warrants per unit | shares		354,000
Threshold per share price during future capital raise | $ / shares	$ 1.00
Preferred Warrants | Series A Preferred
STOCKHOLDERS' EQUITY
Number of warrants per unit | shares		354,000
Warrants fair value		$ 117,131
Amount of warrants allocated to preferred stock		$ 1,073,446